Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Seritage Growth Properties Q3 2026: Net Loss Narrows

Seritage Growth Properties filed its quarterly report on Form 10-Q with the SEC on November 13, 2026, covering the period ended September 30, 2026, disclosing a net income of $3.96 million for the third quarter and a net loss of $32.49 million for the …

Shwetambri Chauhan | 13 November 2026

United Acquisition Corp. I Q3 2026: Trust Account and Deficit Details

United Acquisition Corp. I filed its Form 10-Q for the quarter ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 13, 2026, reporting a net loss of $15,242 for the three-month period and net income of $1,036,102 for the nine …

Nitish Kishor | 13 November 2026

CKX Lands Q3 2026: Net Income Rises to $444,020

CKX Lands, Inc. filed its quarterly report on Form 10-Q with the SEC on November 13, 2026, covering the three and nine months ended September 30, 2026, disclosing net income of $444,020 for the third quarter and $621,499 for the nine-month period.

Vinay Lochav | 13 November 2026

Origin Investment Corp I Reports Q3 2026 Results

Origin Investment Corp I filed a Form 10-Q with the SEC on November 13, 2026, covering the quarterly period ended September 30, 2026, disclosing financial results and balance sheet data for the Singapore-based Cayman Islands blank-check company.

Aditi Sarkar | 13 November 2026

American Strategic Investment Q3 2026 Results Announced

American Strategic Investment Co. filed a Form 8-K on November 13, 2026, announcing its results of operations and supplemental financial information for the quarter ended September 30, 2026.

Vinay Lochav | 13 November 2026

Blue Line Holdings Posts $12,459 Net Loss in September 2026 Quarter

Blue Line Holdings Inc. filed a Form 10-Q with the SEC on November 13, 2026, covering the fiscal quarter ended September 30, 2026, disclosing continued operating losses and a stockholders' deficit for the development-stage company.

Vinay Lochav | 13 November 2026

Evofem Biosciences Reports Q3 2026 Financial Results

Evofem Biosciences, Inc. filed a Current Report on Form 8-K on November 13, 2026, announcing the release of its financial results for the three and nine months ended September 30, 2026.

Aakashdeep | 13 November 2026

American Strategic Investment Reports Q3 2026 Net Loss

American Strategic Investment Co. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 13, 2026, reporting a net loss of $6.724 million for the third quarter.

Aakashdeep | 13 November 2026

Bioscience Health Innovations Posts Q3 2026 Net Loss of $149,225

Bioscience Health Innovations Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission, reporting a net loss for both the three-month and nine-month periods ending on that date.

Nitish Kishor | 13 November 2026

INVE Technologies Q3 2026: Asset Sale Boosts Quarter to Profit

INVE Technologies, Inc. filed its quarterly report on Form 10-Q with the SEC on November 13, 2026, covering the fiscal quarter and nine months ended September 30, 2026.

Manish Choudhary | 13 November 2026
Support

Hi! How can we help you today?

Loading…